Kenneth Touw

Kenneth Touw has a diverse and extensive work experience in the pharmaceutical and research industries. Kenneth began their career as a Postdoctoral Fellow at the University of Iowa in 1978. Kenneth then moved on to become an Assistant Professor at the University at Buffalo in 1980. In 1985, they joined Burroughs Wellcome Co. as a Clinical Research Scientist I, later progressing to the role of Clinical Research Scientist II. In 1991, they transitioned to Burrough Wellcome Co. and served as a Senior Clinical Research Scientist until 1995.

From 1995 to 2000, Kenneth worked at Quintiles, holding various positions including Senior Clinical Research Scientist, Associate Director of NDA/PLA Operations, Director of Regulatory Affairs, and Senior Director of Regulatory & Technical Services. Kenneth then joined King Pharmaceuticals in 2000 and held roles such as Senior Director of Regulatory Affairs, Vice President of Regulatory Affairs, and Senior Vice President until 2011.

Kenneth concluded their career at Cempra Pharmaceuticals, where they served as the Executive Vice President of Regulatory Affairs from December 2011 until present (no specified end date given). Throughout their career, Kenneth Touw has gained extensive experience in regulatory affairs and research, making him a valuable asset in the pharmaceutical and research industries.

Kenneth Touw pursued their education in a chronological order. From 1965 to 1970, they attended Duke University where they completed their Bachelor of Arts degree majoring in Zoology and English. Following this, they enrolled at the University of North Carolina at Chapel Hill School of Medicine from 1973 to 1978, where they earned their Ph.D. in Pharmacology. These are the educational milestones in Kenneth Touw's academic journey.